Literature DB >> 29761318

Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Farzaneh Asgari-Taee1, Nahid Zerafati-Shoae2, Mohsen Dehghani3, Masoumeh Sadeghi4, Hamid R Baradaran5, Shima Jazayeri1.   

Abstract

PURPOSE: The relationship between consumption of sugar sweetened beverages (SSB) and NAFLD has been reported in several epidemiological studies, but the results are inconsistent. The present systematic review and meta-analysis of observational studies was carried out to assess the relationship between sugar sweetened beverages consumption and NAFLD.
METHODS: Online databases were searched systematically through December, 2016 for studies investigating association between SSB consumption and NAFLD but limited to observational studies in human. Pooled odds ratio (OR) and 95% confidence intervals were calculated using Der-Simonian and Laird method while random effects meta-analysis was used, taking into account conceptual heterogeneity. Heterogeneity was assessed with the Cochran Q statistic and quantified with the I2 statistic.
RESULTS: Of the 1015 identified articles, 42 were reviewed in depth and six studies (four cross-sectional, one case-control, and one cohort) met the criteria for inclusion in our systematic review with 6326 participants and 1361 cases of NAFLD in both men and women. Finally, four cross-sectional studies were included in the meta-analysis. Higher intake of SSBs (highest compared to lowest categories) was significantly associated with NAFLD, with a 40% increased Odds of NAFLD after adjusting for important potential confounders (pooled odds ratio 1.40; 95% CI 1.07, 1.82). There was no evidence for significant heterogeneity across studies [P = 0.226 (Q statistics), I2 = 31.0%]. A significant positive association between SSB consumption and NAFLD was observed consistently in a sensitivity analysis [range of summary ORs 1.39-1.49]. There was no evidence of publication bias for the association between SSB and NAFLD.
CONCLUSIONS: This meta-analysis supports a positive significant association between higher consumption of SSB and NAFLD in both men and women. These findings strengthen the evidence that intake of SSBs should be limited to reduce fatty liver disease.

Entities:  

Keywords:  Meta-analysis; NAFLD; Risk factors; Sugar-sweetened beverage

Year:  2018        PMID: 29761318     DOI: 10.1007/s00394-018-1711-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  23 in total

Review 1.  Nonalcoholic fatty liver disease: lifestyle and quality of life.

Authors:  Ilias Vachliotis; Antonis Goulas; Paraskevi Papaioannidou; Stergios A Polyzos
Journal:  Hormones (Athens)       Date:  2021-12-01       Impact factor: 2.885

Review 2.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

Review 3.  Diet and exercise in NAFLD/NASH: Beyond the obvious.

Authors:  Georg Semmler; Christian Datz; Thomas Reiberger; Michael Trauner
Journal:  Liver Int       Date:  2021-08-21       Impact factor: 8.754

4.  Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adults.

Authors:  Ryoko Tajima; Fumiaki Imamura; Takeshi Kimura; Satomi Kobayashi; Katsunori Masuda; Kaoruko Iida
Journal:  Clin Nutr       Date:  2019-07-26       Impact factor: 7.324

Review 5.  Dietary Fructose and the Metabolic Syndrome.

Authors:  Marja-Riitta Taskinen; Chris J Packard; Jan Borén
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

Review 6.  Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications.

Authors:  Claudio Tana; Stefano Ballestri; Fabrizio Ricci; Angelo Di Vincenzo; Andrea Ticinesi; Sabina Gallina; Maria Adele Giamberardino; Francesco Cipollone; Richard Sutton; Roberto Vettor; Artur Fedorowski; Tiziana Meschi
Journal:  Int J Environ Res Public Health       Date:  2019-08-26       Impact factor: 3.390

7.  Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis.

Authors:  Hongwei Chen; Jue Wang; Zheng Li; Christopher Wai Kei Lam; Ying Xiao; Qibiao Wu; Wei Zhang
Journal:  Int J Environ Res Public Health       Date:  2019-06-21       Impact factor: 3.390

8.  Impact of XPF rs2276466 polymorphism on cancer susceptibility: a meta-analysis.

Authors:  Yezhou Liu; Kun Liu; Xueru Zhao; Yidan Sun; Ning Ma; Longmei Tang; Haitao Yang; Xia Gao; Lina Yan; Meina Yuan; Bingshuang Wang; Xiaolin Zhang; Jinhai Jia
Journal:  Biosci Rep       Date:  2019-05-23       Impact factor: 3.840

Review 9.  Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Authors:  Hannele Yki-Järvinen; Panu K Luukkonen; Leanne Hodson; J Bernadette Moore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-13       Impact factor: 46.802

10.  Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Stefano Bellentani
Journal:  Nutrients       Date:  2018-08-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.